Aspire Biopharma Stock Alpha and Beta Analysis
| ASBP Stock | 1.55 0.04 2.52% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aspire BioPharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aspire BioPharma over a specified time horizon. Remember, high Aspire BioPharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aspire BioPharma's market risk premium analysis include:
Beta 0.2 | Alpha (0.95) | Risk 11.68 | Sharpe Ratio (0.08) | Expected Return (0.92) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Aspire BioPharma Analysis, Aspire BioPharma Valuation, Aspire BioPharma Correlation, Aspire BioPharma Hype Analysis, Aspire BioPharma Volatility, Aspire BioPharma Price History and analyze Aspire BioPharma Performance. Aspire BioPharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aspire BioPharma market risk premium is the additional return an investor will receive from holding Aspire BioPharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aspire BioPharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aspire BioPharma's performance over market.| α | -0.95 | β | 0.20 |
Aspire BioPharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Aspire BioPharma's Buy-and-hold return. Our buy-and-hold chart shows how Aspire BioPharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Aspire BioPharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Aspire BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aspire BioPharma shares will generate the highest return on investment. By understating and applying Aspire BioPharma stock market price indicators, traders can identify Aspire BioPharma position entry and exit signals to maximize returns.
Aspire BioPharma Return and Market Media
The median price of Aspire BioPharma for the period between Fri, Nov 21, 2025 and Thu, Feb 19, 2026 is 3.8 with a coefficient of variation of 38.8. The daily time series for the period is distributed with a sample standard deviation of 1.25, arithmetic mean of 3.23, and mean deviation of 1.12. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Fell Donald G. of 10500 shares of Aspire BioPharma, at 0. subject to Rule 16b-3 | 11/28/2025 |
2 | Aspire Biopharma Provides Q3 2025 Business Update | 12/04/2025 |
3 | Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax - for Rapid Anxiety Relief | 01/20/2026 |
4 | Aspire Biopharmas Unveils Bold New Era for BUZZ BOMB Caffeine with Dynamic Website and Packaging Redesign | 01/21/2026 |
5 | Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB Units Featuring Modernized Brand Identity | 01/22/2026 |
6 | Aspire Biopharma Holdings raises 2 million through debenture sale - Investing.com | 01/30/2026 |
7 | Aspire Biopharmas Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution | 02/03/2026 |
8 | Aspire Biopharma Holdings files for Series A convertible preferred stock on Nasdaq - Investing.com | 02/06/2026 |
9 | Aspire Biopharma Announces 21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to... | 02/11/2026 |
10 | Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron | 02/12/2026 |
11 | Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine | 02/17/2026 |
About Aspire BioPharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aspire or other stocks. Alpha measures the amount that position in Aspire BioPharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aspire BioPharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aspire BioPharma's short interest history, or implied volatility extrapolated from Aspire BioPharma options trading.
Build Portfolio with Aspire BioPharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma's price analysis, check to measure Aspire BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma is operating at the current time. Most of Aspire BioPharma's value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma's price. Additionally, you may evaluate how the addition of Aspire BioPharma to your portfolios can decrease your overall portfolio volatility.